Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy
- Authors
- Kim, HR[Kim, Hye Ryun]; Jang, JS[Jang, Joung Soon]; Sun, JM[Sun, Jong-Mu]; Ahn, MJ[Ahn, Myung-Ju]; Kim, DW[Kim, Dong-Wan]; Jung, I[Jung, Inkyung]; Moon, YW[Moon, Yong-Wha]; Lim, SM[Lim, Sun Min]; Jeong, JH[Jeong, Jae Heon]; Lee, KH[Lee, Ki Hyeong]; Kim, JH[Kim, Joo-Hang]; Lee, DH[Lee, Dae Ho]; Kim, SW[Kim, Sang-We]; Cho, BC[Cho, Byoung Chul]
- Issue Date
- Sep-2015
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- non-small cell lung cancer; EGFR; gefitinib; EGFR monoclonal antibody
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.10, no.9, pp.S663 - S664
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 10
- Number
- 9
- Start Page
- S663
- End Page
- S664
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.